Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/2003
12/18/2003WO2003103662A2 Inhibitors of glycoprotein vi
12/18/2003WO2003103604A2 Gamma lactams as prostaglandin agonists and use thereof
12/18/2003WO2003103584A2 Ether substituted imidazopyridines
12/18/2003WO2003103577A2 Novel recombinant anticoagulant proteins
12/18/2003WO2003103475A2 Prevention and reduction of blood loss
12/18/2003WO2003097052A3 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
12/18/2003WO2003066630A3 Quinolinone derivatives for treating cell proliferation related disorders
12/18/2003WO2003054020A3 Human antibodies against human glycoprotein vi and their use
12/18/2003WO2003051917A3 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
12/18/2003WO2003050108A8 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
12/18/2003WO2003044021A3 Substituted indolizine-like compounds and methods of use
12/18/2003WO2003042405A3 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
12/18/2003WO2003037164A3 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
12/18/2003WO2003029437A3 Secreted proteins
12/18/2003WO2003027234A3 Small organic molecule regulators of cell proliferation
12/18/2003WO2003015700A3 Novel vasoconstrictor cannabinoid analogs
12/18/2003WO2003000864A8 Nucleic acid-associated proteins
12/18/2003WO2002100899A3 Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein
12/18/2003WO2002092781A3 Peptide compounds for counteracting reactive oxygen species and free radicals
12/18/2003WO2002064567A8 Substituted carboxamides as inhibitors of factor xa
12/18/2003WO2002062398A3 Radioactively labelled conjugates of phosphonates
12/18/2003WO2002032435A9 A composition including a platelet activating factor inhibitor and an antioxidant which interferes with the arachidonic acid cascade
12/18/2003US20030233035 Methods and devices for diagnosing and treating choroid plexus failure
12/18/2003US20030232986 Inhibitors of caspases
12/18/2003US20030232865 1,4-Benzofused urea compounds useful in treating cytokine mediated diseases
12/18/2003US20030232846 Caspase inhibitors and uses thereof
12/18/2003US20030232823 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations, and uses thereof
12/18/2003US20030232813 Novel amino substituted pyrimidinone derivatives
12/18/2003US20030232804 Glycinamides as factor Xa inhibitors
12/18/2003US20030232789 Salicylamides as serine protease and factor xa inhibitors
12/18/2003US20030232753 Combined tissue factor methods for coagulation and tumor treatment
12/18/2003US20030232433 The use of stem cells and CD6 depleted stem cells for the induction of tolerance to allogenic transplants and/or for the treatment of leucemia
12/18/2003US20030232349 Nucleic acid and amino acid sequences of proteases and the use of these sequences in the diagnosis and treatment of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, and neurological disorders
12/18/2003US20030232099 Powder and an extract of lotus root joints; improves insulin resistance, for diabetes, obesity, hyperlipidemia, hypertension, thrombosis, Alzheimer's disease and senility
12/18/2003DE10215316C1 Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer Quinoline and isoquinoline derivatives, to a pharmaceutical agent and their use as anti-inflammatory agents
12/18/2003CA2488801A1 Ether substituted imidazopyridines
12/18/2003CA2488798A1 Substituted pyrrolines as kinase inhibitors
12/18/2003CA2488602A1 Substituted pyrrolines as kinase inhibitors
12/18/2003CA2488558A1 Prevention and reduction of blood loss
12/18/2003CA2488403A1 Pharmaceutical formulation
12/18/2003CA2488356A1 Novel therapeutic use of polypodium extracts
12/18/2003CA2488246A1 Spliceosome mediated rna trans-splicing and correction of factor viii genetic defects using spliceosome mediated rna trans spling
12/18/2003CA2488193A1 Inhibitors of the gpib -vwf interaction, their preparation and use
12/18/2003CA2488108A1 Liquid formulation of decitabine and use of the same
12/18/2003CA2487924A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
12/18/2003CA2487838A1 Methods and compounds for inhibiting the cytokine or biological activity of mif
12/18/2003CA2486491A1 4-(aryl or heteroaryl)-2-butylamine derivatives and their use as glucocorticoid ligans
12/18/2003CA2486362A1 Novel recombinant anticoagulant proteins
12/18/2003CA2483555A1 Gamma lactams as prostaglandin agonists and use thereof
12/18/2003CA2461444A1 Antithrombogenic platiniferous ceramic composition and article containing the same
12/17/2003EP1371728A1 Gene encoding adseverin
12/17/2003EP1371663A1 Thrombin derivatives and process for producing the same, anhydrothrombin derivatives and process for producing the same, platelet agglutination-inducing compositions, method of inducing platelet agglutination, clinical test reagents, clinical test method, thrombosis inhibitors, adsorbent and process
12/17/2003EP1370685A2 Diagnosis of diseases associated with dna repair
12/17/2003EP1370659A2 Proteins, polynucleotides encoding them and methods of using the same
12/17/2003EP1370654A2 Chimpanzee erythropoietin (chepo) immunoadhesins
12/17/2003EP1370649A1 Protein c variants
12/17/2003EP1370641A2 Use of stem cells and cd6-depleted stem cells for inducing tolerance of allogenic transplants and/or for treating leukaemia
12/17/2003EP1370588A2 Human monoclonal antibodies to fc alpha receptor (cd89)
12/17/2003EP1370586A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370584A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370583A1 Polypeptides and nucleic acids for bolekine
12/17/2003EP1370580A2 A new essential downstream component of the wingless signalling pathway
12/17/2003EP1370573A2 Low molecular serine protease inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals
12/17/2003EP1370561A2 Tetrahydro-pyrazino[1,2-a]indoles for the treatment of central nervous disorders
12/17/2003EP1370560A1 Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists
12/17/2003EP1370556A1 Metalloproteinase inhibitors
12/17/2003EP1370553A2 Rho-kinase inhibitors
12/17/2003EP1370552A2 Rho-kinase inhibitors
12/17/2003EP1370546A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications
12/17/2003EP1370540A1 Anti-thrombotic carboxylic acid amides, the production thereof and use of the same as medicaments
12/17/2003EP1370538A1 Metalloproteinase inhibitors
12/17/2003EP1370537A1 Metalloproteinase inhibitors
12/17/2003EP1370535A1 Metalloproteinase inhibitors
12/17/2003EP1370534A1 Metalloproteinase inhibitors
12/17/2003EP1370533A2 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors
12/17/2003EP1370530A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
12/17/2003EP1370526A1 Diamides which inhibit tryptase and factor xa activity
12/17/2003EP1370522A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
12/17/2003EP1370292A1 Use of cd23 antagonists for the treatment of neoplastic disorders
12/17/2003EP1370288A2 Method for treating thrombocytopenia with monoclonal ivig
12/17/2003EP1370279A2 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies
12/17/2003EP1370276A2 Medical uses of intercellular communication facilitating compounds
12/17/2003EP1370266A1 Method of treatment
12/17/2003EP1370260A2 Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
12/17/2003EP1370248A1 Compositions and methods for preventing platenet aggegation
12/17/2003EP1272470B1 Amorphous torasemide modification
12/17/2003EP1162970B1 Anti-inflammatory uses of manzamines
12/17/2003EP1115414B1 Inhibition of erythrocyte sickling by n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester
12/17/2003EP1098878B1 Bispiperidines as antithrombotic agents
12/17/2003EP1032370B1 Porous hydroxyapatite particles as carriers for drug substances
12/17/2003CN1462195A Pharmaceutical compositions comprising dendritic cells for immunotherapy of automimmune disease and treatment methods using the same
12/17/2003CN1462192A Blood cell production via activation of hemeglobin scavenger receptor
12/17/2003CN1462190A The use of copolymer 1 and related peptides and polypeptides and T cell treated therewith for neuroprotective therapy
12/17/2003CN1461655A Thrombolytics enzyme contg. venin for injection
12/17/2003CN1461654A Medicinal extract for tonifying kidney and enriching blood made from foetal fuzz, and its prepn. method
12/17/2003CN1131058C Chinese medicine for treating blood viscosity and its preparing process
12/16/2003US6664393 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
12/16/2003US6664264 Thioether substituted imidazoquinolines
12/16/2003US6664255 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
12/16/2003US6664249 Bicyclic vasopressin agonists
1 ... 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 ... 671